MedPath

Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study

Not yet recruiting
Conditions
Bladder Cancer
Robot-assisted Radical Cystectomy
Interventions
Procedure: Robot-assisted radical cystectomy
Registration Number
NCT05856825
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Brief Summary

A multicenter, retrospective research was conducted. Patients who underwent robot-assisted radical cystectomy (RARC) from for bladder cancer in 32 institutions in China were enrolled in this study. Baseline condition, perioperative, pathological, and survival outcome were collected. The study was aimed to report the real-world condition of RARC in China, and evaluate its effectiveness.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
4500
Inclusion Criteria
  • >18 years old; Clinical stage Ta-T4a/N0-3/M0.
Exclusion Criteria
  • Severe cardiovascular disease; history of previous major abdominopelvic surgery; patients with distant metastases; medical history of malignancy in other organs.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
The First Affiliated Hospital of Nanjing Medical UniversityRobot-assisted radical cystectomy-
Gansu Provincial HospitalRobot-assisted radical cystectomy-
The Affiliated Yantai Yuhuangding Hospital of Qingdao UniversityRobot-assisted radical cystectomy-
The First Hospital of China Medical UniversityRobot-assisted radical cystectomy-
General Hospital of Central Theater CommandRobot-assisted radical cystectomy-
The East Campus of Qingdao Municipal HospitalRobot-assisted radical cystectomy-
Second Hospital of Dalian Medical UniversityRobot-assisted radical cystectomy-
The First Hospital of Jilin UniversityRobot-assisted radical cystectomy-
Changzheng Hospital, Naval Medical UniversityRobot-assisted radical cystectomy-
Peking Union Medical College HospitalRobot-assisted radical cystectomy-
The First Affiliated Hospital of Chongqing Medical UniversityRobot-assisted radical cystectomy-
Beijing United Family Hospital and ClinicsRobot-assisted radical cystectomy-
The First Affiliated Hospital of Navy Medical UniversityRobot-assisted radical cystectomy-
Zhongda Hospital Southeast UniversityRobot-assisted radical cystectomy-
The Second Xiangya Hospital, Central South UniversityRobot-assisted radical cystectomy-
Southwest Hospital, Third Military Medical Hospital (Army Medical University)Robot-assisted radical cystectomy-
Kunming First People's HospitalRobot-assisted radical cystectomy-
The second Affiliated Hospital of Kunming Medical UniversityRobot-assisted radical cystectomy-
The Third Medical Centre of Chinese PLA General HospitalRobot-assisted radical cystectomy-
The First Affiliated Hospital of Zhengzhou UniversityRobot-assisted radical cystectomy-
The First Affiliated Hospital of Nanchang UniversityRobot-assisted radical cystectomy-
Sichuan Academy of Medical Sciences & Sichuan Provincial People's HospitalRobot-assisted radical cystectomy-
The Third Xiangya Hospital of Central South UniversityRobot-assisted radical cystectomy-
Renji Hospital, Shanghai Jiaotong University School of MedicineRobot-assisted radical cystectomy-
Tongji Hospital Affiliated to Tongji Medical College HustRobot-assisted radical cystectomy-
The First Affiliated Hospital of Xi'an Jiaotong UniversityRobot-assisted radical cystectomy-
Sun Yat-sen Memorial HospitalRobot-assisted radical cystectomy-
Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical CollegeRobot-assisted radical cystectomy-
The Second Affiliated Hospital of Xi'an Jiaotong UniversityRobot-assisted radical cystectomy-
Zhejiang Cancer HospitalRobot-assisted radical cystectomy-
West China Hospital, Sichuan UniversityRobot-assisted radical cystectomy-
Peking University Third HospitalRobot-assisted radical cystectomy-
Primary Outcome Measures
NameTimeMethod
Recurrence-free survivalFive years

Time from surgery to tumor recurrence which identified either pathologically or radiographically

Cancer-specific survivalFive years

Time from date of surgery to death due to bladder cancer

Overall survivalFive years

Time from surgery until death from any cause

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath